Drug Profile
Research programme: ELOVL6 inhibitors - Banyu
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Banyu
- Class Indoles; Pyrazoles
- Mechanism of Action ELOVL6 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Diabetes-mellitus in Japan (PO)
- 09 Jun 2009 Preclinical trials in Diabetes mellitus in Japan (PO)